An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08
Swedish (OMX) Healthcare Sector Analysis
UpdatedJun 08, 2023
DataAggregated Company Financials
Companies225
- 7D1.3%
- 3M4.4%
- 1Y-11.2%
- YTD5.8%
Over the last 7 days, the Healthcare industry has risen 1.3%, driven by gains from Medicover of 7.9%. In the same time, BICO Group was down 22%. However, the industry is down 11% over the past year. Looking forward, earnings are forecast to grow by 32% annually.
Sector Valuation and Performance
Has the Swedish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 08 Jun 2023 | kr513.2b | kr179.0b | -kr543,106,564.00 | 41.1x | -944.9x | 2.9x |
| Sat, 06 May 2023 | kr530.4b | kr176.4b | -kr736,383,535.00 | 41.1x | -720.3x | 3x |
| Mon, 03 Apr 2023 | kr494.5b | kr172.5b | -kr1,399,898,502.00 | 35.6x | -353.2x | 2.9x |
| Wed, 01 Mar 2023 | kr493.0b | kr171.6b | -kr1,163,811,380.00 | 37.3x | -423.6x | 2.9x |
| Fri, 27 Jan 2023 | kr512.4b | kr166.1b | kr533.7m | 33.7x | 960.1x | 3.1x |
| Sun, 25 Dec 2022 | kr468.6b | kr165.7b | kr699.4m | 31.4x | 670x | 2.8x |
| Tue, 22 Nov 2022 | kr484.4b | kr164.6b | kr1.1b | 31x | 456.2x | 2.9x |
| Thu, 20 Oct 2022 | kr450.8b | kr159.7b | -kr242,804,819.00 | 29.5x | -1856.7x | 2.8x |
| Sat, 17 Sep 2022 | kr450.4b | kr159.4b | -kr112,034,488.00 | 31.2x | -4020.1x | 2.8x |
| Mon, 15 Aug 2022 | kr539.3b | kr156.8b | -kr359,297,300.00 | 32.3x | -1501x | 3.4x |
| Wed, 13 Jul 2022 | kr521.8b | kr153.8b | kr312.9m | 33.5x | 1667.3x | 3.4x |
| Fri, 10 Jun 2022 | kr544.2b | kr155.2b | kr382.8m | 37.1x | 1421.8x | 3.5x |
| Sun, 08 May 2022 | kr517.6b | kr152.6b | kr792.5m | 38.3x | 653.2x | 3.4x |
| Tue, 05 Apr 2022 | kr648.2b | kr147.5b | kr1.2b | 45.8x | 526.1x | 4.4x |
| Thu, 03 Mar 2022 | kr595.2b | kr147.8b | kr1.9b | 38.1x | 308.1x | 4x |
| Sat, 29 Jan 2022 | kr630.3b | kr144.3b | kr3.3b | 44.7x | 188.4x | 4.4x |
| Mon, 27 Dec 2021 | kr758.1b | kr143.9b | kr3.5b | 51.5x | 217.1x | 5.3x |
| Wed, 24 Nov 2021 | kr754.2b | kr143.2b | kr3.9b | 51.1x | 191.9x | 5.3x |
| Fri, 22 Oct 2021 | kr765.5b | kr138.6b | kr3.4b | 56.1x | 222.9x | 5.5x |
| Sun, 19 Sep 2021 | kr785.7b | kr140.4b | kr4.1b | 58x | 191.5x | 5.6x |
| Tue, 17 Aug 2021 | kr747.8b | kr140.4b | kr4.4b | 53.3x | 168.3x | 5.3x |
| Tue, 01 Jun 2021 | kr595.3b | kr135.3b | kr2.0b | 45.9x | 293.1x | 4.4x |
| Fri, 05 Mar 2021 | kr535.3b | kr134.6b | kr1.8b | 47.5x | 297.2x | 4x |
| Mon, 07 Dec 2020 | kr490.7b | kr133.6b | kr2.3b | 34x | 218.1x | 3.7x |
| Thu, 10 Sep 2020 | kr473.1b | kr131.0b | kr1.8b | 41.9x | 263x | 3.6x |
Price to Earnings Ratio
233.9x
Current Industry PE
- Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare sector?
| SE Market | 3.44% | |
| Healthcare | 1.28% | |
| Healthcare Services | 6.36% | |
| Biotech | 2.38% | |
| Healthtech | 0.98% | |
| Medical Equipment | 0.58% | |
| Life Sciences | -0.26% | |
| Pharma | -2.20% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 58.4%, which is higher than its past year's earnings growth of 19.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 58% over the next 5 years.
- This is better than its past earnings growth rate of 19% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 19% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SOBI Swedish Orphan Biovitrum | kr222.60 | 5.0% +kr3.1b | 7.8% | PE20.9x | |
| BIOA B BioArctic | kr336.40 | 3.1% +kr899.9m | 343.2% | PE90.8x | |
| EKTA B Elekta | kr83.48 | 2.3% +kr710.7m | 8.1% | PE33.8x | |
| SECT B Sectra | kr185.40 | 1.7% +kr594.0m | 33.7% | PE95.3x | |
| BACTI B Bactiguard Holding | kr81.40 | 18.3% +kr441.6m | -21.6% | PS12.3x |
